Medications

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...

Immunology

Study reveals hidden diversity of innate immune cells

Findings from a new study, led by researchers at Dartmouth's Geisel School of Medicine and published in Nature Immunology, have uncovered key functional differences in macrophages—a type of white blood cell that plays a ...

Oncology & Cancer

A new look at cancer treatments during pregnancy

For an OB-GYN, one of the worst-case scenarios runs like this: A woman comes in, overjoyed that she is finally pregnant after years of fertility treatments. Then a month later, she finds out she has cancer—news that is ...

page 3 from 40